Treatment-related survival patterns in diffuse intrinsic pontine glioma using a historical cohort: A report from the European Society for Pediatric Oncology DIPG/DMG Registry.

Autor: Baugh JN; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Veldhuijzen van Zanten S; Department of Radiology and Nuclear Medicine, Erasmus University Medical Center, Rotterdam, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Fiocco M; Department of Biomedical Data Sciences, Section Medical Statistics, Leiden University Medical Center, Leiden, The Netherlands.; Mathematical Institute, Leiden University, Leiden, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Colditz N; Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., Hoffmann M; Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., Janssens GO; Department of Radiation Oncology, University Medical Center Utrecht, Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Valentini C; National Center for Tumor Diseases, with DKFZ Heidelberg, University Hospital and Faculty of Medicine Dresden and Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.; Department of Radiotherapy and Radiation Oncology, Faculty of Medicine, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.; Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., Hargrave D; Great Ormond Street Hospital for Children, NHS Trust London, London, UK., Wiese M; Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany., von Bueren AO; Division of Pediatric Hematology and Oncology, Department of Pediatrics, Gynecology and Obstetrics, University Hospital of Geneva, Geneva, Switzerland., Karremann M; Department of Pediatric and Adolescent Medicine, University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany., Perwein T; Division of Pediatric Hemato-Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria., Nussbaumer G; Division of Pediatric Hemato-Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria., Benesch M; Division of Pediatric Hemato-Oncology, Department of Pediatrics and Adolescent Medicine, Medical University of Graz, Graz, Austria., Sturm D; Department of Pediatric Oncology, Hematology, & Immunology, Heidelberg University Hospital, Heidelberg, Germany.; Division of Pediatric Glioma Research, German Cancer Research Center (DKFZ) and German Consortium for Translational Cancer Research (DKTK), Heidelberg, Germany.; Hopp Children's Cancer Center Heidelberg (KiTZ), Heidelberg, Germany., Gielen GH; Department of Neuropathology, University Hospital Bonn, Bonn, Germany., Krause M; Department Translational Radiooncology and Clinical Radiotherapy, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany.; German Cancer Consortium (DKTK) Dresden and German Cancer Research Center (DKFZ), Heidelberg, Germany.; National Center for Tumor Diseases, with DKFZ Heidelberg, University Hospital and Faculty of Medicine Dresden and Institute of Radiooncology - OncoRay, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany., Eyrich M; Department of Pediatric Hematology, Oncology, and Stem Cell Transplantation, University Hospital Würzburg, Würzburg, Germany., Hoving EW; Department of Pediatric Neurosurgery, Utrecht University Medical Center/Wilhelmina Children's Hospital, Utrecht, The Netherlands.; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Bison B; Diagnostic and Interventional Neuroradiology, Faculty of Medicine, University of Augsburg, Augsburg, Germany., van Vuurden DG; Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands., Kramm CM; Division of Pediatric Hematology and Oncology, University Medical Center Göttingen, Göttingen, Germany.

Publikováno v: Neuro-oncology advances [Neurooncol Adv] 2024 Sep 10; Vol. 6 (1), pp. vdae155. Date of Electronic Publication: 2024 Sep 10 (Print Publication: 2024).

T2-FLAIR Mismatch: An Imaging Biomarker for Children's MYB/MYBL1 -Altered Diffuse Astrocytoma or Angiocentric Glioma.

Autor: van Maren EA; From the Department of Radiology and Nuclear Medicine (E.A.v.M., J.W.D., M.H.L.), University Medical Center Utrecht, Utrecht, the Netherlands., Dankbaar JW; From the Department of Radiology and Nuclear Medicine (E.A.v.M., J.W.D., M.H.L.), University Medical Center Utrecht, Utrecht, the Netherlands j.w.dankbaar@umcutrecht.nl., Wesseling P; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands.; Department of Pathology (P.W.), Amsterdam University Medical Centers/VU Medical Center, Amsterdam, the Netherlands., Plasschaert S; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands., Muhlebner A; Department of Pathology (A.M.), University Medical Center Utrecht, Utrecht, the Netherlands., Hoving EW; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands.; Department of Neurosurgery (E.W.H., P.A.R.), University Medical Center Utrecht, Utrecht, the Netherlands., Robe PA; Department of Neurosurgery (E.W.H., P.A.R.), University Medical Center Utrecht, Utrecht, the Netherlands., Snijders TJ; Department of Neurology (T.J.S.), UMC Utrecht Brain Center, University Medical Center Utrecht, Utrecht, the Netherlands., Hoogendijk R; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands., Kranendonk MEG; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands., Lequin MH; From the Department of Radiology and Nuclear Medicine (E.A.v.M., J.W.D., M.H.L.), University Medical Center Utrecht, Utrecht, the Netherlands.; Princess Máxima Center for Pediatric Oncology (P.W., S.P., E.W.H., R.H., M.E.G.K., M.H.L.), Utrecht, the Netherlands.

Publikováno v: AJNR. American journal of neuroradiology [AJNR Am J Neuroradiol] 2024 Jun 07; Vol. 45 (6), pp. 747-752. Date of Electronic Publication: 2024 Jun 07.

Protocol for investigating data quality and reporting outcomes of pediatric gliomas in population-based cancer registry research.

Autor: Hoogendijk R; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. Electronic address: r.hoogendijk@prinsesmaximacentrum.nl., van der Lugt J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Kranendonk MEG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Gatta G; Evaluative Epidemiology Unit, Department of Epidemiology and Data Science, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Capocaccia R; Editorial Board, Epidemiol Prev, Milan, Italy., Hoving EW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Neurosurgery, University Medical Center Utrecht, Utrecht, the Netherlands., Wesseling P; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Pathology, Amsterdam University Medical Centers, Amsterdam, the Netherlands., Visser O; Department of Research and Innovation, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands., van Vuurden DG; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., Karim-Kos H; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands; Department of Research and Innovation, Netherlands Comprehensive Cancer Organization (IKNL), Utrecht, The Netherlands. Electronic address: h.e.karim-kos@prinsesmaximacentrum.nl.

Publikováno v: STAR protocols [STAR Protoc] 2024 Mar 15; Vol. 5 (1), pp. 102905. Date of Electronic Publication: 2024 Feb 22.

Robotic alignment system Cirq (Brainlab) for navigated brain tumor biopsies in children.

Autor: van Baarsen KM; Department of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands. k.m.vanbaarsen-4@prinsesmaximacentrum.nl.; Department of Pediatric Neurosurgery, Utrecht University Medical Center/Wilhelmina Children's Hospital, Utrecht, The Netherlands. k.m.vanbaarsen-4@prinsesmaximacentrum.nl., Woodley DEA; Department of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Department of Pediatric Neurosurgery, Utrecht University Medical Center/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Slot KM; Department of Neurosurgery, Amsterdam University Medical Centers, Amsterdam, The Netherlands., Woerdeman PA; Department of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Department of Pediatric Neurosurgery, Utrecht University Medical Center/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Han KS; Department of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Department of Pediatric Neurosurgery, Utrecht University Medical Center/Wilhelmina Children's Hospital, Utrecht, The Netherlands., Hoving EW; Department of Neuro-Oncology, Princess Máxima Center for Pediatric Oncology, Heidelberglaan 25, 3584 CS, Utrecht, The Netherlands.; Department of Pediatric Neurosurgery, Utrecht University Medical Center/Wilhelmina Children's Hospital, Utrecht, The Netherlands.

Publikováno v: Child's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery [Childs Nerv Syst] 2024 Jan; Vol. 40 (1), pp. 99-108. Date of Electronic Publication: 2023 Jul 12.

SMARCB1 loss activates patient-specific distal oncogenic enhancers in malignant rhabdoid tumors.

Autor: Liu NQ; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Department of Hematology, Erasmus Medical Center (MC) Cancer Institute, Rotterdam, the Netherlands., Paassen I; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Custers L; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Zeller P; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute-KNAW, Utrecht, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands., Teunissen H; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands., Ayyildiz D; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., He J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Buhl JL; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Oncode Institute, Utrecht, the Netherlands., Hoving EW; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands., van Oudenaarden A; Oncode Institute, Utrecht, the Netherlands.; Hubrecht Institute-KNAW, Utrecht, the Netherlands.; University Medical Center Utrecht, Utrecht, the Netherlands., de Wit E; Division of Gene Regulation, Netherlands Cancer Institute, Amsterdam, the Netherlands. e.d.wit@nki.nl., Drost J; Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands. J.Drost@prinsesmaximacentrum.nl.; Oncode Institute, Utrecht, the Netherlands. J.Drost@prinsesmaximacentrum.nl.

Publikováno v: Nature communications [Nat Commun] 2023 Dec 01; Vol. 14 (1), pp. 7762. Date of Electronic Publication: 2023 Dec 01.